MKI67 and breast carcinoma: Additionally, no statistically significant difference was noted in the average percentage of Ki67-positive cancer cells on day 0 (5.8%) versus day 5 (5.5%), p = 0.92, among samples of all tissue types (n = 16) of breast cancer, urothelial carcinoma and colorectal cancer (Figure 1C).